Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Royalty Pharma PLC (RPRX) had Receiveable Turnover of 64.25 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$2.35B |
|
$1.13B |
|
-- |
|
$2.35B |
|
$862.40M |
|
$1.49B |
|
$207.94M |
|
$1.70B |
|
$1.47B |
|
$1.70B |
|
$1.70B |
|
$1.70B |
|
$1.47B |
|
$1.49B |
|
$1.51B |
|
447.60M |
|
602.90M |
|
$2.54 |
|
$2.53 |
|
| Balance Sheet Financials | |
$1.27B |
|
$14.09B |
|
$15.11B |
|
$16.38B |
|
$161.38M |
|
$6.14B |
|
$6.14B |
|
$6.30B |
|
$10.08B |
|
$10.08B |
|
$10.08B |
|
982.12M |
|
| Cash Flow Statement Financials | |
$2.99B |
|
$-2.07B |
|
$-2.15B |
|
$1.71B |
|
$477.01M |
|
$-1.23B |
|
$2.36M |
|
$-854.85M |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.90 |
|
-- |
|
-- |
|
0.38 |
|
0.61 |
|
100.00% |
|
63.37% |
|
63.37% |
|
64.24% |
|
72.20% |
|
48.20% |
|
$2.99B |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
-- |
|
|
Receiveable Turnover |
64.25 |
5.68 |
|
16.86% |
|
16.86% |
|
10.38% |
|
10.48% |
|
$10.27 |
|
$4.96 |
|
$4.96 |
|